ClinVar Miner

Submissions for variant NM_001128425.1(MUTYH):c.820C>T (p.Arg274Trp) (rs769237459)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000519616 SCV000617563 likely pathogenic not provided 2017-09-06 criteria provided, single submitter clinical testing This variant is denoted MUTYH c.820C>T at the cDNA level, p.Arg274Trp (R274W) at the protein level,and results in the change of an Arginine to a Tryptophan (CGG>TGG). Also published as MUTYH c.778C>T andArg260Trp (R260W) using alternate nomenclature, this variant has been observed in the compound heterozygous statein at least three individuals with polyposis and/or colorectal cancer, including two siblings (Aceto 2005, Aretz 2006, Vogt2009, Aceto 2015). MUTYH Arg274Trp has also been observed in at least one individual with breast cancer (Tung2016). This variant was described as functionally defective following interrogation in a MutY-Deficient E. colicomplementation assay (Komine 2015). MUTYH Arg274Trp was not observed at a significant allele frequency in largepopulation cohorts (NHLBI Exome Sequencing Project, The 1000 Genomes Consortium 2015, Lek 2016). SinceArginine and Tryptophan differ in polarity, charge, size or other properties, this is considered a non-conservative aminoacid substitution. MUTYH Arg274Trp occurs at a position that is conserved across species and is not located in aknown functional domain. In silico analyses predict that this variant is probably damaging to protein structure andfunction. Based on currently available evidence, we consider MUTYH Arg274Trp to be a likely pathogenic variant
Ambry Genetics RCV000570778 SCV000662627 likely pathogenic Hereditary cancer-predisposing syndrome 2020-09-09 criteria provided, single submitter clinical testing The p.R274W variant (also known as c.820C>T), located in coding exon 10 of the MUTYH gene, results from a C to T substitution at nucleotide position 820. The arginine at codon 274 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in the literature in a compound heterozygous state with another MUTYH mutation in multiple individuals with adenomatous polyposis and/or GI cancers (Aceto GM et al, J. Exp. Clin. Cancer Res. 2015 ; 34():131; Aceto G et al, Hum. Mutat. 2005 Oct; 26(4):394; Vogt S et al, Gastroenterology 2009 Dec; 137(6):1976-85.e1-10; Aretz S et al. Int. J. Cancer 2006 Aug;119(4):807-14). A functional analysis of this alteration using E. coli complementation, protein stability, and subcellular localization in mammalian cells indicated that this alteration was functionally defective (Komine K et al, Hum. Mutat. 2015 Jul; 36(7):704-11). Of note, this alteration is also designated as p.R260W (c.778C>T) in published literature. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Color Health, Inc RCV000570778 SCV000690612 likely pathogenic Hereditary cancer-predisposing syndrome 2020-03-10 criteria provided, single submitter clinical testing
Invitae RCV000640346 SCV000761935 likely pathogenic MYH-associated polyposis 2020-10-19 criteria provided, single submitter clinical testing This sequence change replaces arginine with tryptophan at codon 274 of the MUTYH protein (p.Arg274Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs769237459, ExAC 0.002%). This variant has been observed in individual(s) with MUTYH-associated polyposis (PMID: 16134147, 19732775, 19394335, 19032956). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 449417). This variant has been reported to affect MUTYH protein function (PMID: 25820570). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000640346 SCV000967629 likely pathogenic MYH-associated polyposis 2018-09-18 criteria provided, single submitter clinical testing The p.Arg274Trp variant in MUTYH has been reported in the compound heterozygous state at least 2 individuals with MUTYH-associated polyposis (MAP) who had a sec ond pathogenic variant in MUTYH (Aceto 2005, Aretz 2005, Vogt 2009). Additionall y, it segregated with disease in at least one affected family member (Aceto 2005 ). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID: 449417) and has been identified in 1/33562 Latino chromosomes by gnomAD ( In vitro functional studies provide some evidence that the p.Arg274Trp variant may impact protein function (Komine 2 015); however, these types of assays may not accurately represent biological fun ction. Computational prediction tools and conservation analysis support that the p.Arg274Trp variant may impact the protein. In summary, although additional stu dies are required to fully establish its clinical significance, this variant mee ts criteria to be classified as likely pathogenic for autosomal recessive MAP. A CMG/AMP criteria applied: PM2, PM3, PP1, PP3, PS3_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.